These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11940704)

  • 41. Clinical, Radiographic, and Pathologic Findings in Patients Undergoing Reoperation Following Radiation Therapy and Temozolomide for Newly Diagnosed Glioblastoma.
    Ellsworth S; Ye X; Grossman SA
    Am J Clin Oncol; 2017 Jun; 40(3):219-222. PubMed ID: 26491903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Malignant potential of pleomorphic xanthoastrocytoma.
    Vu TM; Liubinas SV; Gonzales M; Drummond KJ
    J Clin Neurosci; 2012 Jan; 19(1):12-20. PubMed ID: 22137880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme.
    Bambury RM; Morris PG
    Expert Rev Anticancer Ther; 2014 Aug; 14(8):955-64. PubMed ID: 24814143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
    Taal W; Oosterkamp HM; Walenkamp AM; Dubbink HJ; Beerepoot LV; Hanse MC; Buter J; Honkoop AH; Boerman D; de Vos FY; Dinjens WN; Enting RH; Taphoorn MJ; van den Berkmortel FW; Jansen RL; Brandsma D; Bromberg JE; van Heuvel I; Vernhout RM; van der Holt B; van den Bent MJ
    Lancet Oncol; 2014 Aug; 15(9):943-53. PubMed ID: 25035291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecularly targeted therapies for recurrent glioblastoma: current and future targets.
    Lau D; Magill ST; Aghi MK
    Neurosurg Focus; 2014 Dec; 37(6):E15. PubMed ID: 25434384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glioblastoma recurrence patterns after radiation therapy with regard to the subventricular zone.
    Adeberg S; König L; Bostel T; Harrabi S; Welzel T; Debus J; Combs SE
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):886-93. PubMed ID: 25220720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme.
    Hong B; Wiese B; Bremer M; Heissler HE; Heidenreich F; Krauss JK; Nakamura M
    Am J Clin Oncol; 2013 Jun; 36(3):261-8. PubMed ID: 22495452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A roundtable discussion on the clinical challenges and options for the treatment of glioblastoma: introducing a novel modality, TTFields.
    Butowski N; Wong ET; Mehta MP; Wilson LK
    Semin Oncol; 2013 Dec; 40(6):S2-4. PubMed ID: 24331200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma.
    Qin L; Li X; Stroiney A; Qu J; Helgager J; Reardon DA; Young GS
    Neuroradiology; 2017 Feb; 59(2):135-145. PubMed ID: 28070598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pentavalent technetium-99m dimercaptosuccinic acid [99m Tc-(V)DMSA] brain scintitomography--a plausible non-invasive depicter of glioblastoma proliferation and therapy response.
    Tsiouris S; Pirmettis I; Chatzipanagiotou T; Ptohis N; Papantoniou V
    J Neurooncol; 2007 Dec; 85(3):291-5. PubMed ID: 17554495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor-free survival of 7 years after gene therapy for recurrent glioblastoma.
    Floeth FW; Langen KJ; Reifenberger G; Weber F
    Neurology; 2003 Jul; 61(2):270-1. PubMed ID: 12874421
    [No Abstract]   [Full Text] [Related]  

  • 52. A feasibility study of the Nativis Voyager
    Murphy M; Dowling A; Thien C; Priest E; Morgan Murray D; Kesari S
    CNS Oncol; 2019 Mar; 8(1):CNS31. PubMed ID: 30727742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma.
    Plotkin M; Gneveckow U; Meier-Hauff K; Amthauer H; Feussner A; Denecke T; Gutberlet M; Jordan A; Felix R; Wust P
    Int J Hyperthermia; 2006 Jun; 22(4):319-25. PubMed ID: 16754352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.
    Jahan N; Lee JM; Shah K; Wakimoto H
    Int J Cancer; 2017 Oct; 141(8):1671-1681. PubMed ID: 28567859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic AAV9-IFNβ gene delivery treats highly invasive glioblastoma.
    GuhaSarkar D; Su Q; Gao G; Sena-Esteves M
    Neuro Oncol; 2016 Nov; 18(11):1508-1518. PubMed ID: 27194146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advanced case of glioblastoma multiforme and pregnancy. An ethical dilemma.
    Al-Rasheedy IM; Al-Hameed FM
    Neurosciences (Riyadh); 2015 Oct; 20(4):388-91. PubMed ID: 26492122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
    Nguyen HN; Lie A; Li T; Chowdhury R; Liu F; Ozer B; Wei B; Green RM; Ellingson BM; Wang HJ; Elashoff R; Liau LM; Yong WH; Nghiemphu PL; Cloughesy T; Lai A
    Neuro Oncol; 2017 Mar; 19(3):394-404. PubMed ID: 27571882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrent Glioblastoma-Molecular Underpinnings and Evolving Treatment Paradigms.
    Chang C; Chavarro VS; Gerstl JVE; Blitz SE; Spanehl L; Dubinski D; Valdes PA; Tran LN; Gupta S; Esposito L; Mazzetti D; Gessler FA; Arnaout O; Smith TR; Friedman GK; Peruzzi P; Bernstock JD
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome of salvage treatment for recurrent glioblastoma.
    Kim HR; Kim KH; Kong DS; Seol HJ; Nam DH; Lim DH; Lee JI
    J Clin Neurosci; 2015 Mar; 22(3):468-73. PubMed ID: 25595963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subventricular zones: new key targets for glioblastoma treatment.
    Khalifa J; Tensaouti F; Lusque A; Plas B; Lotterie JA; Benouaich-Amiel A; Uro-Coste E; Lubrano V; Cohen-Jonathan Moyal E
    Radiat Oncol; 2017 Apr; 12(1):67. PubMed ID: 28424082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.